a public good project by the
Synthesis
Company
of California

© 2026

Xingrui Li | doi.page

0 works0 citations0 h-index

Xingrui Li

Union Hospital(CN)Sichuan University(CN)Wuhan Union Hospital(CN)Stomatology Hospital(CN)Tongji Hospital(CN)Union Hospital(CN)State Key Laboratory of Oral DiseasesHuazhong University of Science and Technology(CN)

Publications by Year

Research Areas

RNA modifications and cancer, Ferroptosis and cancer prognosis, Cancer-related Molecular Pathways, MicroRNA in disease regulation, Advanced Breast Cancer Therapies

Most-Cited Works

→ The interaction of innate immune and adaptive immune system(2024)167 cited
→ miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail(2015)75 cited
→ <p>Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway</p>(2019)74 cited
→ ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in Gliomas(2022)55 cited
→ Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer(2020)38 cited
→ Integrated analysis reveals the participation of IL4I1, ITGB7, and FUT7 in reshaping the TNBC immune microenvironment by targeting glycolysis(2021)32 cited

Increased DJ-1 and its prognostic significance in hepatocellular carcinoma.

(2011)

→ Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high‐level immune infiltration status(2020)24 cited

→ <p>Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer</p>(2020)22 cited

→ NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer(2021)21 cited